ScreenerHero

LBIRD Lumibird SA

EPA · FR · Healthcare · Diagnostics & Research · lumibird.com
23.40EUR-1.68%Mkt Cap: 561.23M $P/E: 36.56

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates thr…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$250.23BUSDP/E 36.4
DHR
Danaher Corporation
$155.51BUSDP/E 39.4
NTRA
Natera, Inc.
$61.35BUSD
LONN
Lonza Group AG
$45.82BUSDP/E 38.1
A
Agilent Technologies, Inc.
$48.29BUSDP/E 33.8
ILMN
Illumina, Inc.
$44.35BUSDP/E 54.8
IQV
IQVIA Holdings Inc.
$43.80BUSDP/E 33.1
WAT
Waters Corporation
$43.21BUSDP/E 111.4
IDXX
IDEXX Laboratories, Inc.
$41.58BUSDP/E 37.0
MTD
Mettler-Toledo International Inc.
$30.89BUSDP/E 34.7
DGX
Quest Diagnostics Incorporated
$25.63BUSDP/E 24.7
GH
Guardant Health, Inc.
$25.12BUSD
LH
Labcorp Holdings Inc.
$25.03BUSDP/E 25.5
RVTY
Revvity, Inc.
$17.56BUSDP/E 75.3
MEDP
Medpace Holdings, Inc.
$17.32BUSDP/E 36.4
CRL
Charles River Laboratories International, Inc.
$14.84BUSD
ERF
Eurofins Scientific SE
$14.05BUSDP/E 26.2
ICLR
ICON Public Limited Company
$12.99BUSDP/E 177.2
BIM
bioMérieux S.A.
$10.02BUSDP/E 20.0
QGEN
Qiagen N.V.
$9.46BUSDP/E 23.2

Key Statistics

Company
Market Cap561.23M USD
Enterprise Value507.57M USD
Revenue (TTM)256.99M USD
Gross Profit158.96M USD
Net Income (TTM)15.23M USD
Revenue/Share10.38 EUR
Last Price23.40 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.1K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)36.56
P/E (Forward)18.17
PEG—
EV/EBITDA14.50
EV/Revenue1.98
P/S2.22
P/B2.54
EPS (TTM)0.64
EPS (Forward)1.31
52W Range
18.7547% of range28.70
52W High28.70 EUR
52W Low18.75 EUR
Profitability
Gross Margin63.99%
Oper. Margin7.50%
EBITDA Margin13.62%
Profit Margin6.13%
ROE6.79%
ROA3.27%
Growth
Revenue Growth5.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF31.52M USD
CapEx (TTM)17.78M USD
FCF Margin12.68%
FCF Yield5.81%
Net Debt-63.26M USD
Net Debt/EBITDA-1.81
Balance Sheet
Debt/Equity0.71
Current Ratio2.49
Quick Ratio0.66
Book Value/Sh9.37 EUR
Cash/Share2.64 EUR
Dividends
Fwd Div Rate0.37 EUR
Trail. Div Rate0.00 EUR
Div. Yield1.55%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 18, 2026
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)31.83 EUR
Upside (mean)+36.0%
Target Range30.00 EUR – 34.00 EUR
30.00+36.0% to mean34.00
# Analysts3
Ownership
Shares Out.22.07M
Float10.38M
Insiders53.58%
Institutions17.78%
Technical
SMA 5025.89 (-9.6%)
SMA 20024.03 (-2.6%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)30.56K
Avg Vol (10d)39.32K
Technical Indicators
RSI (14)35.8
MACD-0.6615
MACD Signal-0.5215
MACD Hist.-0.1399
BB Upper27.01 EUR
BB Middle24.88 EUR
BB Lower22.74 EUR
BB Width17.16%
ATR (14)0.8058 EUR
Vol Ratio (20d)0.81x